Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study

MLA

Antonio Gómez-Centeno, et al. “Clinical and Therapeutic Management of Rheumatoid Arthritis with Biological Disease-Modifying Antirheumatic Drugs: RADAR Study.” Rheumatology International, vol. 39, Aug. 2019, pp. 2015–24. EBSCOhost, https://doi.org/10.1007/s00296-019-04378-6.

APA

Antonio Gómez-Centeno, Santiago Muñoz-Fernández, Ceferino Barbazán-Álvarez, Sagrario Bustabad, Sara Manrique-Arija, Esteban Rubio-Romero, Juan Amarelo-Ramos, Juan Ovalles, Javier del Pino-Montes, & Sara Marsal-Barril. (2019). Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study. Rheumatology International, 39, 2015–2024. https://doi.org/10.1007/s00296-019-04378-6

Chicago

Antonio Gómez-Centeno, Santiago Muñoz-Fernández, Ceferino Barbazán-Álvarez, Sagrario Bustabad, Sara Manrique-Arija, Esteban Rubio-Romero, Juan Amarelo-Ramos, Juan Ovalles, Javier del Pino-Montes, and Sara Marsal-Barril. 2019. “Clinical and Therapeutic Management of Rheumatoid Arthritis with Biological Disease-Modifying Antirheumatic Drugs: RADAR Study.” Rheumatology International 39 (August): 2015–24. doi:10.1007/s00296-019-04378-6.